McKesson Ventures, LLC - 26 Sep 2022 Form 4 Insider Report for Augmedix, Inc.

Role
10%+ Owner
Signature
/s/ David Schulte, Senior Vice President and Managing Director of MCKESSON VENTURES, LLC
Issuer symbol
N/A
Transactions as of
26 Sep 2022
Net transactions value
-$15,914
Form type
4
Filing time
28 Sep 2022, 16:02:43 UTC
Previous filing
27 Sep 2022
Next filing
30 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Sale $3,588 -2,300 -0.06% $1.56 4,022,340 26 Sep 2022 Direct F1
transaction AUGX Common Stock Sale $12,326 -7,337 -0.18% $1.68 4,015,003 27 Sep 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.64. The Reporting Persons undertake to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.62 to $1.80. The Reporting Persons undertake to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.